【SCI Pharmtech】March 2026 Revenue NT$128 Million (YoY -24.4%)
SCI Pharmtech's revenue for March 2026 was NT$128 million, a decrease of 24.4% year-over-year. The company is in the Biotechnology and Medical Care industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 21:27 (4h 57m after Collected)
Company Ticker: 4119
Company Name: SCI Pharmtech
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 127,606 thousand TWD (128 million)
Year-over-Year Change: -24.4%
Company Name: SCI Pharmtech
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 127,606 thousand TWD (128 million)
Year-over-Year Change: -24.4%
FAQ
How was SCI Pharmtech's revenue in March 2026?
It was TWD 128 million, a sharp decline of 24.4% year-over-year.
What kind of company is SCI Pharmtech?
It is a company that develops and manufactures active pharmaceutical ingredients (APIs) for pharmaceutical companies.
Why did SCI Pharmtech's revenue decrease significantly?
The likely reasons include a temporary decrease in orders from its pharmaceutical clients or a lack of shipments for certain products.